Corporate News
Tavexia Lifecare Limited, formerly Sattva Sukun Lifecare, announced several key decisions following a board meeting held September 7, 2026. The company authorized the exploration of acquiring shares of Meyonex Pharmaceuticals Limited, a pharmaceutical company with a registered address in Palghar, Maharashtra, and an authorized capital of Rs 20,00,00,000. Additionally, the board accepted the resignation of M/s. SSRV and Associates as Statutory Auditors, effective immediately, and appointed M/s DEVAM & Associates LLP to the role, pending shareholder approval at the next Annual General Meeting. Mrs. Khushboo Vasudev was also re-appointed as an Independent Director for a second five-year term, also subject to shareholder approval. The Managing Director or Company Secretary will handle the AGM notice and e-voting process, in compliance with SEBI regulations.